{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:33:20Z","timestamp":1763037200733,"version":"3.37.3"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Major Project of China","award":["2017ZX10202101-003, 2017ZX10301101-001 and 2017ZX09309008-003"],"award-info":[{"award-number":["2017ZX10202101-003, 2017ZX10301101-001 and 2017ZX09309008-003"]}]},{"name":"State Key Laboratory of Infectious Disease Prevention and Control","award":["2015SKLID506"],"award-info":[{"award-number":["2015SKLID506"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81271826","81201286"],"award-info":[{"award-number":["81271826","81201286"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12879-018-3153-2","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T07:09:40Z","timestamp":1528096180000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Polymorphisms in the Th17 cell-related RORC gene are associated with spontaneous clearance of HCV in Chinese women"],"prefix":"10.1186","volume":"18","author":[{"given":"Zhe","family":"Xie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuantao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Liang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1365-9862","authenticated-orcid":false,"given":"Tao","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"issue":"1","key":"3153_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","volume":"61","author":"JP Messina","year":"2015","unstructured":"Messina JP, Humphreys I, Flaxman A, Brown A, Cooke GS, Pybus OG, Barnes E. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2015;61(1):77\u201387.","journal-title":"Hepatology"},{"issue":"5","key":"3153_CR2","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1111\/jgh.13709","volume":"32","author":"JH Kao","year":"2017","unstructured":"Kao JH, Ahn SH, Chien RN, Cho M, Chuang WL, Jeong SH, Liu CH, Paik SW. Urgency to treat patients with chronic hepatitis C in Asia. J Gastroenterol Hepatol. 2017;32(5):966\u201374.","journal-title":"J Gastroenterol Hepatol"},{"issue":"3","key":"3153_CR3","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1007\/s12072-015-9629-x","volume":"9","author":"H Bennett","year":"2015","unstructured":"Bennett H, Waser N, Johnston K, Kao JH, Lim YS, Duan ZP, Lee YJ, Wei L, Chen CJ, Sievert W, et al. A review of the burden of hepatitis C virus infection in China, Japan South Korea and Taiwan. Hepatol Int. 2015;9(3):378\u201390.","journal-title":"Hepatol Int"},{"issue":"4","key":"3153_CR4","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1002\/hep.26141","volume":"57","author":"K Mohd Hanafiah","year":"2013","unstructured":"Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013;57(4):1333\u201342.","journal-title":"Hepatology"},{"key":"3153_CR5","doi-asserted-by":"publisher","first-page":"31485","DOI":"10.1038\/srep31485","volume":"6","author":"J Huang","year":"2016","unstructured":"Huang J, Huang K, Xu R, Wang M, Liao Q, Xiong H, Li C, Tang X, Shan Z, Zhang M, et al. The associations of HLA-A*02:01 and DRB1*11:01 with hepatitis C virus spontaneous clearance are independent of IL28B in the Chinese population. Sci Rep. 2016;6:31485.","journal-title":"Sci Rep"},{"issue":"11","key":"3153_CR6","doi-asserted-by":"publisher","first-page":"e27555","DOI":"10.1371\/journal.pone.0027555","volume":"6","author":"CH van den Berg","year":"2011","unstructured":"van den Berg CH, Grady BP, Schinkel J, van de Laar T, Molenkamp R, van Houdt R, Coutinho RA, van Baarle D, Prins M. Female sex and IL28B, a synergism for spontaneous viral clearance in hepatitis C virus (HCV) seroconverters from a community-based cohort. PLoS One. 2011;6(11):e27555.","journal-title":"PLoS One"},{"issue":"6","key":"3153_CR7","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1002\/hep.27164","volume":"60","author":"L Alric","year":"2014","unstructured":"Alric L, Bonnet D, Fort M. Association between female sex, IL28B genotype, but also DQB1*0301 allele and the outcome of acute hepatitis C virus infection. Hepatology. 2014;60(6):2127.","journal-title":"Hepatology"},{"issue":"3","key":"3153_CR8","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s00705-015-2703-9","volume":"161","author":"H Ikezaki","year":"2016","unstructured":"Ikezaki H, Furusyo N, Hiramine S, Ura K, Mitsumoto-Kaseida F, Takayama K, Shimizu M, Toyoda K, Ogawa E, Kainuma M, et al. Association of IL28B rs8099917 genotype and female sex with spontaneous clearance of hepatitis C virus infection: a Japanese cross-sectional study. Arch Virol. 2016;161(3):641\u20138.","journal-title":"Arch Virol"},{"issue":"1","key":"3153_CR9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/hep.26639","volume":"59","author":"J Grebely","year":"2014","unstructured":"Grebely J, Page K, Sacks-Davis R, van der Loeff MS, Rice TM, Bruneau J, Morris MD, Hajarizadeh B, Amin J, Cox AL, et al. The effects of female sex, viral genotype, and IL28B genotype on spontaneous clearance of acute hepatitis C virus infection. Hepatology. 2014;59(1):109\u201320.","journal-title":"Hepatology"},{"issue":"3","key":"3153_CR10","doi-asserted-by":"publisher","first-page":"6496","DOI":"10.3390\/ijms16036496","volume":"16","author":"N Moqueet","year":"2015","unstructured":"Moqueet N, Infante-Rivard C, Platt RW, Young J, Cooper C, Hull M, Walmsley S, Klein MB. Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in aboriginals in Canadian HIV-hepatitis C co-infected individuals. Int J Mol Sci. 2015;16(3):6496\u2013512.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3153_CR11","first-page":"379","volume":"36","author":"J Peng","year":"2015","unstructured":"Peng J, Chen X, He J, Zheng J, Qin B, Jiang Y. Relationship between interleukin 28B, equilibrative nucleoside transporters 1 gene polymorphisms and spontaneous clearance of HCV in HIV\/HCV co-infectors. Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi. 2015;36(4):379\u201382.","journal-title":"Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi"},{"issue":"5","key":"3153_CR12","doi-asserted-by":"publisher","first-page":"e37054","DOI":"10.1371\/journal.pone.0037054","volume":"7","author":"X Shi","year":"2012","unstructured":"Shi X, Pan Y, Wang M, Wang D, Li W, Jiang T, Zhang P, Chi X, Jiang Y, Gao Y, et al. IL28B genetic variation is associated with spontaneous clearance of hepatitis C virus, treatment response, serum IL-28B levels in Chinese population. PLoS One. 2012;7(5):e37054.","journal-title":"PLoS One"},{"issue":"3","key":"3153_CR13","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1365-2893.2011.01497.x","volume":"19","author":"HY Rao","year":"2012","unstructured":"Rao HY, Sun DG, Jiang D, Yang RF, Guo F, Wang JH, Liu F, Zhang HY, Zhang HH, Du SC, et al. IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection. J Viral Hepat. 2012;19(3):173\u201381.","journal-title":"J Viral Hepat"},{"issue":"4","key":"3153_CR14","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s15010-014-0608-2","volume":"42","author":"E Sagnelli","year":"2014","unstructured":"Sagnelli E, Santantonio T, Coppola N, Fasano M, Pisaturo M, Sagnelli C. Acute hepatitis C: clinical and laboratory diagnosis, course of the disease, treatment. Infection. 2014;42(4):601\u201310.","journal-title":"Infection"},{"issue":"5685","key":"3153_CR15","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1126\/science.1097670","volume":"305","author":"SI Khakoo","year":"2004","unstructured":"Khakoo SI, Thio CL, Martin MP, Brooks CR, Gao X, Astemborski J, Cheng J, Goedert JJ, Vlahov D, Hilgartner M, et al. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science. 2004;305(5685):872\u20134.","journal-title":"Science"},{"issue":"2","key":"3153_CR16","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/1751-2980.12202","volume":"16","author":"ZX Dong","year":"2015","unstructured":"Dong ZX, Zhou HJ, Xiang XG, Guo SM, Zhuang Y, Zhao GD, Xie Q. IL28B genetic variations are associated with treatment response of patients with chronic hepatitis C in a Chinese Han population. J Dig Dis. 2015;16(2):90\u20137.","journal-title":"J Dig Dis"},{"key":"3153_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.meegid.2013.10.009","volume":"21","author":"G Jin","year":"2014","unstructured":"Jin G, Kang H, Chen X, Dai D. Evaluation of the relationship between IL28B, IL10RB and IL28RA single-nucleotide polymorphisms and susceptibility to hepatitis C virus in Chinese Han population. Infec Genet Evol. 2014;21:8\u201314.","journal-title":"Infec Genet Evol"},{"issue":"2","key":"3153_CR18","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3851\/IMP1703","volume":"16","author":"XW Liao","year":"2011","unstructured":"Liao XW, Ling Y, Li XH, Han Y, Zhang SY, Gu LL, Yu DM, Yao BL, Zhang DH, Jin GD, et al. Association of genetic variation in IL28B with hepatitis C treatment-induced viral clearance in the Chinese Han population. Antivir Ther. 2011;16(2):141\u20137.","journal-title":"Antivir Ther"},{"key":"3153_CR19","doi-asserted-by":"publisher","first-page":"651503","DOI":"10.1155\/2014\/651503","volume":"2014","author":"JF Zambrano-Zaragoza","year":"2014","unstructured":"Zambrano-Zaragoza JF, Romo-Martinez EJ, Duran-Avelar Mde J, Garcia-Magallanes N, Vibanco-Perez N. Th17 cells in autoimmune and infectious diseases. Int J Inflamm. 2014;2014:651503.","journal-title":"Int J Inflamm"},{"issue":"4","key":"3153_CR20","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1124\/pr.58.4.10","volume":"58","author":"G Benoit","year":"2006","unstructured":"Benoit G, Cooney A, Giguere V, Ingraham H, Lazar M, Muscat G, Perlmann T, Renaud JP, Schwabe J, Sladek F, et al. International Union of Pharmacology LXVI. Orphan nuclear receptors. Pharmacol Rev. 2006;58(4):798\u2013836.","journal-title":"Pharmacol Rev"},{"issue":"5475","key":"3153_CR21","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1126\/science.288.5475.2369","volume":"288","author":"Z Sun","year":"2000","unstructured":"Sun Z, Unutmaz D, Zou YR, Sunshine MJ, Pierani A, Brenner-Morton S, Mebius RE, Littman DR. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science. 2000;288(5475):2369\u201373.","journal-title":"Science"},{"issue":"1","key":"3153_CR22","first-page":"13","volume":"50","author":"P Balanescu","year":"2012","unstructured":"Balanescu P, Ladaru A, Voiosu T, Nicolau A, Ene M, Balanescu E. Th17 and IL-17 immunity in chronic hepatitis C infection. Rom J Intern Med. 2012;50(1):13\u20138.","journal-title":"Rom J Intern Med"},{"issue":"2","key":"3153_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1111\/j.1440-1746.2011.06782.x","volume":"27","author":"Q Chang","year":"2012","unstructured":"Chang Q, Wang YK, Zhao Q, Wang CZ, Hu YZ, Wu BY. Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C. J Gastroenterol Hepatol. 2012;27(2):273\u20138.","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"3153_CR24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.1365-2893.2011.01561.x","volume":"19","author":"HQ Sun","year":"2012","unstructured":"Sun HQ, Zhang JY, Zhang H, Zou ZS, Wang FS, Jia JH. Increased Th17 cells contribute to disease progression in patients with HBV-associated liver cirrhosis. J Viral Hepat. 2012;19(6):396\u2013403.","journal-title":"J Viral Hepat"},{"issue":"12","key":"3153_CR25","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1097\/TP.0b013e31823817f5","volume":"92","author":"AB Seetharam","year":"2011","unstructured":"Seetharam AB, Borg BB, Subramanian V, Chapman WC, Crippin JS, Mohanakumar T. Temporal association between increased virus-specific Th17 response and spontaneous recovery from recurrent hepatitis C in a liver transplant recipient. Transplantation. 2011;92(12):1364\u201370.","journal-title":"Transplantation"},{"issue":"6","key":"3153_CR26","doi-asserted-by":"publisher","first-page":"e1003422","DOI":"10.1371\/journal.ppat.1003422","volume":"9","author":"H Kared","year":"2013","unstructured":"Kared H, Fabre T, Bedard N, Bruneau J, Shoukry NH. Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C. PLoS Pathog. 2013;9(6):e1003422.","journal-title":"PLoS Pathog"},{"issue":"4","key":"3153_CR27","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.vaccine.2010.11.023","volume":"29","author":"J Chen","year":"2011","unstructured":"Chen J, Liang Z, Lu F, Fang X, Liu S, Zeng Y, Zhu F, Chen X, Shen T, Li J, et al. Toll-like receptors and cytokines\/cytokine receptors polymorphisms associate with non-response to hepatitis B vaccine. Vaccine. 2011;29(4):706\u201311.","journal-title":"Vaccine"},{"issue":"4","key":"3153_CR28","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1478-3231.2011.02449.x","volume":"31","author":"M Romero-Gomez","year":"2011","unstructured":"Romero-Gomez M, Eslam M, Ruiz A, Maraver M. Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment. Liver Int. 2011;31(4):443\u201360.","journal-title":"Liver Int"},{"issue":"6","key":"3153_CR29","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/MOH.0b013e32833e7544","volume":"17","author":"S Selvarajah","year":"2010","unstructured":"Selvarajah S, Tobler LH, Simmons G, Busch MP. Host genetic basis for hepatitis C virus clearance: a role for blood collection centers. Curr Opin Hematol. 2010;17(6):550\u20137.","journal-title":"Curr Opin Hematol"},{"issue":"7262","key":"3153_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nature08309","volume":"461","author":"D Ge","year":"2009","unstructured":"Ge D, Fellay J, Thompson AJ, Simon JS, Shianna KV, Urban TJ, Heinzen EL, Qiu P, Bertelsen AH, Muir AJ, et al. Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance. Nature. 2009;461(7262):399\u2013401.","journal-title":"Nature"},{"issue":"10","key":"3153_CR31","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/ng.447","volume":"41","author":"V Suppiah","year":"2009","unstructured":"Suppiah V, Moldovan M, Ahlenstiel G, Berg T, Weltman M, Abate ML, Bassendine M, Spengler U, Dore GJ, Powell E, et al. IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet. 2009;41(10):1100\u20134.","journal-title":"Nat Genet"},{"issue":"10","key":"3153_CR32","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/ng.449","volume":"41","author":"Y Tanaka","year":"2009","unstructured":"Tanaka Y, Nishida N, Sugiyama M, Kurosaki M, Matsuura K, Sakamoto N, Nakagawa M, Korenaga M, Hino K, Hige S, et al. Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C. Nat Genet. 2009;41(10):1105\u20139.","journal-title":"Nat Genet"},{"issue":"7265","key":"3153_CR33","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/nature08463","volume":"461","author":"DL Thomas","year":"2009","unstructured":"Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O'Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, et al. Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature. 2009;461(7265):798\u2013801.","journal-title":"Nature"},{"issue":"22","key":"3153_CR34","doi-asserted-by":"publisher","first-page":"11094","DOI":"10.1128\/JVI.00912-06","volume":"80","author":"S Gaudieri","year":"2006","unstructured":"Gaudieri S, Rauch A, Park LP, Freitas E, Herrmann S, Jeffrey G, Cheng W, Pfafferott K, Naidoo K, Chapman R, et al. Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J Virol. 2006;80(22):11094\u2013104.","journal-title":"J Virol"},{"issue":"5","key":"3153_CR35","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/ng.3835","volume":"49","author":"MA Ansari","year":"2017","unstructured":"Ansari MA, Pedergnana V, LCI C, Magri A, Von Delft A, Bonsall D, Chaturvedi N, Bartha I, Smith D, Nicholson G, et al. Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. Nat Genet. 2017;49(5):666\u201373.","journal-title":"Nat Genet"},{"issue":"5572","key":"3153_CR36","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1126\/science.1069660","volume":"296","author":"CB Moore","year":"2002","unstructured":"Moore CB, John M, James IR, Christiansen FT, Witt CS, Mallal SA. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level. Science. 2002;296(5572):1439\u201343.","journal-title":"Science"},{"issue":"1","key":"3153_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1136\/gutjnl-2014-308724","volume":"65","author":"A von Delft","year":"2016","unstructured":"von Delft A, Humphreys IS, Brown A, Pfafferott K, Lucas M, Klenerman P, Lauer GM, Cox AL, Gaudieri S, Barnes E. The broad assessment of HCV genotypes 1 and 3 antigenic targets reveals limited cross-reactivity with implications for vaccine design. Gut. 2016;65(1):112\u201323.","journal-title":"Gut"},{"issue":"24","key":"3153_CR38","doi-asserted-by":"publisher","first-page":"15661","DOI":"10.1073\/pnas.202608299","volume":"99","author":"R Thimme","year":"2002","unstructured":"Thimme R, Bukh J, Spangenberg HC, Wieland S, Pemberton J, Steiger C, Govindarajan S, Purcell RH, Chisari FV. Viral and immunological determinants of hepatitis C virus clearance, persistence.and disease. Proc Nati Acad Sci USA. 2002;99(24):15661\u20138.","journal-title":"Proc Nati Acad Sci USA"},{"issue":"10","key":"3153_CR39","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1084\/jem.194.10.1395","volume":"194","author":"R Thimme","year":"2001","unstructured":"Thimme R, Oldach D, Chang KM, Steiger C, Ray SC, Chisari FV. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J Exp Med. 2001;194(10):1395\u2013406.","journal-title":"J Exp Med"},{"issue":"8","key":"3153_CR40","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1136\/gutjnl-2011-300620","volume":"61","author":"P Klenerman","year":"2012","unstructured":"Klenerman P, Thimme R. T cell responses in hepatitis C: the good the bad and the unconventional. Gut. 2012;61(8):1226\u201334.","journal-title":"Gut"},{"issue":"4","key":"3153_CR41","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1111\/j.1600-6143.2011.03458.x","volume":"11","author":"HI Basha","year":"2011","unstructured":"Basha HI, Subramanian V, Seetharam A, Nath DS, Ramachandran S, Anderson CD, Shenoy S, Chapman WC, Crippin JS, Mohanakumar T. Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2011;11(4):775\u201385.","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg"},{"issue":"8","key":"3153_CR42","doi-asserted-by":"publisher","first-page":"4372","DOI":"10.1128\/JVI.03376-12","volume":"87","author":"JM Wang","year":"2013","unstructured":"Wang JM, Shi L, Ma CJ, Ji XJ, Ying RS, Wu XY, Wang KS, Li G, Moorman JP, Yao ZQ. Differential regulation of interleukin-12 (IL-12)\/IL-23 by Tim-3 drives T(H)17 cell development during hepatitis C virus infection. J Virol. 2013;87(8):4372\u201383.","journal-title":"J Virol"},{"issue":"8","key":"3153_CR43","doi-asserted-by":"publisher","first-page":"e23550","DOI":"10.1371\/journal.pone.0023550","volume":"6","author":"T Shen","year":"2011","unstructured":"Shen T, Chen X, Zhang W, Xi Y, Cao G, Zhi Y, Wang S, Xu C, Wei L, Lu F, et al. A higher correlation of HCV core antigen with CD4+ T cell counts compared with HCV RNA in HCV\/HIV-1 coinfected patients. PLoS One. 2011;6(8):e23550.","journal-title":"PLoS One"},{"issue":"7","key":"3153_CR44","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1086\/423943","volume":"190","author":"M Jauncey","year":"2004","unstructured":"Jauncey M, Micallef JM, Gilmour S, Amin J, White PA, Rawlinson W, Kaldor JM, van Beek I, Dore GJ. Clearance of hepatitis C virus after newly acquired infection in injection drug users. J Infect Dis. 2004;190(7):1270\u20134.","journal-title":"J Infect Dis"},{"issue":"4","key":"3153_CR45","doi-asserted-by":"publisher","first-page":"488","DOI":"10.3390\/ijms17040488","volume":"17","author":"A Paradowska-Gorycka","year":"2016","unstructured":"Paradowska-Gorycka A, Stypinska B, Pawlik A, Romanowska-Prochnicka K, Haladyj E, Manczak M, Olesinska M. RORC2 genetic variants and serum levels in patients with rheumatoid arthritis. Int J Mol Sci. 2016;17(4):488.","journal-title":"Int J Mol Sci"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3153-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-018-3153-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-018-3153-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T19:03:42Z","timestamp":1559588622000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-018-3153-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["3153"],"URL":"https:\/\/doi.org\/10.1186\/s12879-018-3153-2","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"assertion":[{"value":"19 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the institutional review authorities of Peking University Health Science Center (Approval ID: PKUPHLL20090011). All patients provided written informed consent before enrollment in the study.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"254"}}